Amgen Inc
(AMGN-NASDAQ)
DRUGS - Biotechnology
Stock report updated on 01/20/2012
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| Closing price: |
$69.57 |
| Support price level: |
$58.61 |
| Resistance price level: |
N/A |
| Relative strength index (14-day RSI): |
79.9 |
| Beta: |
0.50 |
52-Week Range
| Low |
High |
Price as % of Range |
| $48.27 |
$69.57 |
100.0% |
Moving Averages
| 200 day |
50 day |
20 day |
10 day |
| $57.31 |
$60.68 |
$65.60 |
$67.22 |
Volatility (annualized std. dev.)
Historical
(5 year) |
Last month |
Current estimate |
Next month forecast |
| 29.9% |
24.6% |
22.4% |
26.9% |
Value at Risk
There is an estimated 5% probability that the stock price of Amgen Inc will fall by more than:
- 6.1% in the next week.
- 15.2% in the next month.
- 42.6% in the next year.
Company News for Amgen Inc
Google Finance |
MSN Money |
Reuters
Reports for Other Stocks
